A NEW IDEA ON BLUEPRINT MEDICINE $BPMC $IBB $XBI $BBH $BIS
This post was just published on ZYX Buy Change Alert. BPMC is a biotech firm focused on developing cancer treatment therapies. This is a new IPO. It is a high risk high reward situation suitable only for aggressive investors as the risk of loss is high. Here is the plan: Consider buying
April 30, 2015